eyestock logo

eyestock

4S

Acousort ABFRA Acousort

Последний отчетный период 30 июня, 2023

Обновлено 17 окт., 2024

Последняя цена

Капитализация млрд. $

0.028

Micro

Биржа

XFRA - Deutsche Boerse AG

Анализ акций 4SA.F

4S

Нет оценки

Количественный анализ Eyestock не покрывает акции Acousort AB.

Капитализация млрд. $

0.028

Дивидендная доходность

Оборот

13.202 млрд

Сайт компании

http://acousort.com/

AcouSort AB engages in the provision of biotechnology. The company is headquartered in Lund, Skane. The company went IPO on 2017-01-09. The firm develops, produces and sells standalone laboratory products and integrated original equipment manufacturer (OEM) solutions where ultrasound is used to separate, wash and enrich cells, exosomes and other biological particles for research and diagnostics. Its product portfolio includes AcouWash and AcouTrap that are targeting separation, washing and enrichment applications within cell, bacteria and extracellular vesicle research. In addition, the Company develops proprietary bioanalytical and clinical applications based on acoustophoresis, and offers custom-developed acoustophoresis applications.

Смотреть Секцию: Рейтинг